...
机译:乙型肝炎前培养筛查:南澳大利亚的依从性研究
Hepatology and Liver Transplant Medicine Unit Flinders Medical CentreAdelaide South Australia;
Department of MedicineThe Queen Elizabeth HospitalAdelaide South Australia Australia;
Department of PharmacyFlinders Medical CentreAdelaide South Australia Australia;
Department of PharmacyFlinders Medical CentreAdelaide South Australia Australia;
Department of HaematologyFlinders Medical CentreAdelaide South Australia Australia;
Department of Medical Oncology Flinders Medical CentreFlinders Centre for Innovation and Cancer;
Department of GastroenterologyLyell McEwin HospitalAdelaide South Australia Australia;
Centre for Epidemiology and BiostatisticsFlinders UniversityAdelaide South Australia Australia;
Hepatology and Liver Transplant Medicine Unit Flinders Medical CentreAdelaide South Australia;
Hepatology and Liver Transplant Medicine Unit Flinders Medical CentreAdelaide South Australia;
rituximab; hepatitis B; immunosuppression; lymphoma; entecavir;
机译:乙型肝炎前培养筛查:南澳大利亚的依从性研究
机译:坚持乙肝筛查和预防性拉米夫定预防利妥昔单抗相关的乙肝再激活
机译:在克罗恩氏病生物治疗之前进行筛查:遵守指南和感染率。多中心回顾性研究的结果。
机译:131I-利妥昔单抗在放射免疫治疗中的放射内部剂量测定
机译:增强利妥昔单抗治疗:分析利妥昔单抗与人类补体途径之间的相互作用。
机译:一项多中心队列试验研究的研究方案该试验方案在西澳大利亚州大都市和地区实施了扩展的孕前携带者筛查计划
机译:在澳大利亚悉尼患有慢性乙型肝炎的人群中不坚持抗病毒治疗和肝细胞癌筛查的利用。